General Updates

Date: 6th November 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544595 Scrip Symbol: ORKLAINDIA Subject: Intimation of grant of employee stock options under the Orkla India Limited Employee Stock Option Plan 2025 Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of Orkla India Limited (“Company”), by way of a circular resolution passed on 5th November 2026, has approved the grant of 11,11,850 (Eleven Lakh Eleven Thousand Eight Hundred and Fifty) employee stock options (“Options”), to eligible employees under the Orkla India Limited Employee Stock Option Plan 2025 (“ESOP 2025” or “Plan”). The grant has been made in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 and the terms of ESOP 2025. The details required under Regulation 30 of the SEBI Listing Regulations read with the applicable SEBI circular are enclosed as the Annexure. The aforesaid information will also be made available on the website of the Company at https://www.orklaindia.com/investor-relations/. You are requested to kindly take the above information on record. Thanking you, For Orkla India Limited (Formerly known as Orkla India Private Limited) Kaushik Seshadri Company Secretary and Compliance Officer ORKLA INDIA LIMITED (Formerly known as “Orkla India Private Limited”) Registered Office: No. 1, 2nd & 3rd Floor, 100 Feet Inner Ring Road, Ejipura, Ashwini Layout, Vivek Nagar, Bengaluru - 560 047, India CIN: L15136KA1996PLC021007 | T: +91 80 4081 2100/7 | Website: www.orklaindia.com | E-mail: contactus@orklaindia.com Annexure Details of grant of employee stock options under ESOP 2025 Disclosure under Regulation 30 of the SEBI Listing Regulations read with the applicable SEBI circular. Sr. No. Particulars Details 1 Brief details of options granted 11,11,850 (Eleven Lakh Eleven Thousand Eight Hundred and Fifty) employee stock options have been granted by the Nomination and Remuneration Committee to eligible employees under ESOP 2025 plan. 2 Whether the scheme is in terms of Yes. the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 3 Total number of shares covered by 11,11,850 (Eleven Lakh Eleven Thousand Eight Hundred and Fifty) the Options Options, exercisable into not more than 11,11,850 (Eleven Lakh Eleven Thousand Eight Hundred and Fifty) fully paid-up equity shares of the Company, with each Option entitling the holder to one equity share, subject to adjustments under ESOP 2025. 4 Pricing formula / exercise price The exercise price is ₹702.90 (Rupees Seven Hundred Two and Paise Ninety only) per Option, as approved by the Nomination and Remuneration Committee in accordance with ESOP 2025. The price has been determined with reference to the closing market price of ₹528.10 per equity share on NSE on 4th November 2026 and the approved pricing methodology as per ESOP 2025. 5 Options vested Not applicable. 6 Time within which the Options During employment with the Company, vested Options may be may be exercised exercised within 2 (Two) years from the relevant vesting date in terms of the Plan. 7 Options exercised Not applicable. The present disclosure relates to the grant of stock options. 8 Money realised by exercise of Not applicable. The present disclosure relates to the grant of stock Options options. 9 Total number of shares arising as a Not applicable at the grant stage. Upon exercise, each Option will result of exercise of Options entitle the holder to one equity share. 10 Options lapsed Not applicable. The present disclosure relates to the grant of Options. ORKLA INDIA LIMITED (Formerly known as “Orkla India Private Limited”) Registered Office: No. 1, 2nd & 3rd Floor, 100 Feet Inner Ring Road, Ejipura, Ashwini Layout, Vivek Nagar, Bengaluru - 560 047, India CIN: L15136KA1996PLC021007 | T: +91 80 4081 2100/7 | Website: www.orklaindia.com | E-mail: contactus@orklaindia.com Sr. No. Particulars Details 11 Variation of terms of Options Not applicable. 12 Brief details of significant terms The Options will have a fixed vesting period of 3 (Three) years from the Grant Date, inclusive of the minimum vesting period of 1 (One) year prescribed under applicable law and will vest subject to continued employment and satisfaction of the conditions specified in ESOP 2025 and the respective grant letters. During employment, vested Options may be exercised within 2 (Two) years from the relevant vesting date. All other terms are governed by ESOP 2025. 13 Subsequent changes, cancellation Not applicable. The present disclosure relates to the grant of Options. or exercise of the Options 14 Diluted earnings per share Not applicable at the grant stage. pursuant to issue of equity shares on exercise of Options ORKLA INDIA LIMITED (Formerly known as “Orkla India Private Limited”) Registered Office: No. 1, 2nd & 3rd Floor, 100 Feet Inner Ring Road, Ejipura, Ashwini Layout, Vivek Nagar, Bengaluru - 560 047, India CIN: L15136KA1996PLC021007 | T: +91 80 4081 2100/7 | Website: www.orklaindia.com | E-mail: contactus@orklaindia.com